KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Asset Utilization Ratio: 2010-2025

Historic Asset Utilization Ratio for Emergent BioSolutions (EBS) over the last 13 years, with Sep 2025 value amounting to 0.55.

  • Emergent BioSolutions' Asset Utilization Ratio fell 10.95% to 0.55 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.55, marking a year-over-year decrease of 10.95%. This contributed to the annual value of 0.65 for FY2024, which is 54.45% up from last year.
  • Per Emergent BioSolutions' latest filing, its Asset Utilization Ratio stood at 0.55 for Q3 2025, which was down 8.49% from 0.60 recorded in Q2 2025.
  • Emergent BioSolutions' Asset Utilization Ratio's 5-year high stood at 0.65 during Q1 2024, with a 5-year trough of 0.32 in Q1 2023.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.55 (2025), whereas its average is 0.54.
  • Per our database at Business Quant, Emergent BioSolutions' Asset Utilization Ratio crashed by 46.13% in 2023 and then skyrocketed by 104.61% in 2024.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Asset Utilization Ratio stood at 0.61 in 2021, then crashed by 39.45% to 0.37 in 2022, then skyrocketed by 53.16% to 0.56 in 2023, then rose by 3.61% to 0.59 in 2024, then decreased by 10.95% to 0.55 in 2025.
  • Its Asset Utilization Ratio stands at 0.55 for Q3 2025, versus 0.60 for Q2 2025 and 0.54 for Q1 2025.